Axitinib 1mg, 5mg Tablets
Axitinib 1mg, 5mg tablets are used for the treatment of kidney cancer in humans. The medication comes under the brand name of Inlyta.
Axitinib 1mg, 5mg tablets falls under the category of anti-cancer medications. The tablets work by blocking the action of abnormal protein of cancer cells which signals cell growth. In short, the cancer cells’ growth becomes stunted with the use of Inlyta tablets.
Some interaction reactions are seen with other types of drugs. Hence, it is advised to not use such drugs which reduces the effectiveness of the tablets.
Keep the tablets in a cool place at a normal room temperature. do not try to freeze the medication as it is not good for the effectiveness of the medicine.
1. What is Inlyta?
Inlyta is an anti-cancer medicine containing axitinib, a tyrosine kinase inhibitor. It works by targeting signaling pathways involved in the formation of new blood vessels that can support tumor growth. Inlyta is available as oral film-coated tablets.
2. What is Inlyta used for?
Inlyta (axitinib) is used in the treatment of advanced renal cell carcinoma (RCC). Depending on the applicable prescribing information, it may be used alone after previous systemic therapy or in combination with medicines such as pembrolizumab or avelumab for first-line treatment of advanced RCC.
3. How does Inlyta work?
Axitinib inhibits several receptor tyrosine kinases, including VEGFR-1, VEGFR-2 and VEGFR-3. Blocking these pathways can reduce signaling involved in angiogenesis, or the formation of new blood vessels that tumors may require for continued growth.
4. What strengths of Inlyta are available?
Inlyta is available in 1 mg and 5 mg film-coated tablets. The appropriate strength and dosage are selected by the treating healthcare professional based on the patient’s treatment plan and tolerability.
5. How is Inlyta taken?
Inlyta is taken orally, generally twice daily at approximately 12-hour intervals. It can be taken with or without food and should be used exactly as prescribed. The dosage may be adjusted by the treating physician according to treatment response and adverse reactions.